Better Therapeutics, Inc. announced that it has entered into a Securities Purchase Agreement to issue 1,471,453 common shares, par value $0.0001 per share at a price of $0.1699 per share for the gross proceeds of $249,999.8647 on January 5, 2024. The transaction will include participation from new individual investor David Perry. The closing of the Private Placement is expected to occur on January 9, 2024, and is subject to the satisfaction of customary closing conditions.

The securities issued to the Purchaser under the Purchase Agreement were issued pursuant to an exemption from registration provided for under Section 4(a)(2) of the Securities Act of 1933, as amended and Regulation D promulgated thereunder.